What is Zacks Research’s Forecast for Senestech Q3 Earnings?

Senestech, Inc. (NASDAQ:SNES) – Equities researchers at Zacks Research raised their Q3 2026 earnings estimates for Senestech in a report issued on Thursday, October 22nd. Zacks Research analyst M. Marin now forecasts that the company will earn ($0.31) per share for the quarter, up from their previous estimate of ($0.34). The consensus estimate for Senestech’s current full-year earnings is ($1.28) per share. Zacks Research also issued estimates for Senestech’s Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($1.26) EPS and FY2027 earnings at ($0.98) EPS.

Separately, Weiss Ratings downgraded Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Senestech currently has a consensus rating of “Sell”.

Senestech Stock Performance

Shares of SNES stock opened at $0.84 on Wednesday. Senestech has a twelve month low of $0.55 and a twelve month high of $3.70. The stock’s fifty day simple moving average is $0.87 and its 200 day simple moving average is $1.51.

Senestech (NASDAQ:SNES) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) EPS for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. The firm had revenue of $0.77 million during the quarter, compared to the consensus estimate of $0.60 million.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Senestech stock. Diversify Wealth Management LLC purchased a new stake in Senestech, Inc. (NASDAQ:SNES) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent quarter. Institutional investors and hedge funds own 5.19% of the company’s stock.

Insider Activity at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management acquired 426,000 shares of Senestech stock in a transaction that occurred on Thursday, October 15th. The shares were bought at an average price of $0.77 per share, with a total value of $328,020.00. Following the completion of the purchase, the insider directly owned 1,505,294 shares in the company, valued at $1,159,076.38. This trade represents a 39.47% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have acquired a total of 1,115,169 shares of company stock worth $813,573 in the last quarter. 2.20% of the stock is currently owned by insiders.

About Senestech

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.